This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Akihiro Takano: Innovator in Radiolabeled Compounds
Introduction
Akihiro Takano is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of radiolabeled compounds, particularly in their application as radiotracers for imaging purposes. His work is vital for advancing medical imaging techniques.
Latest Patents
One of Akihiro Takano's notable patents is focused on radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals. The present invention provides radiolabeled compounds that are useful as radiotracers for quantitative imaging of PDE10A in mammals. The compound of the present invention is represented by the formula (I), wherein each symbol is defined in the specification. This innovation holds promise for enhancing diagnostic imaging in medical applications.
Career Highlights
Akihiro Takano is associated with Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. His work at Takeda has allowed him to focus on innovative solutions that address critical healthcare challenges. His expertise in radiolabeled compounds has positioned him as a key player in the field of medical imaging.
Collaborations
Some of his notable coworkers include Takahiko Taniguchi and Shotaro Miura. Their collaboration has contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Akihiro Takano's contributions to the field of radiolabeled compounds exemplify the importance of innovation in medical imaging. His work continues to pave the way for advancements that can significantly impact healthcare.